Endovascular Management of Direct Carotid-cavernous Fistula

Sohag University (Other)
Overall Status
CT.gov ID

Study Details

Study Description

Brief Summary

Carotid-cavernous fistula (CCF) refers to an aberrant arteriovenous communication between the carotid arterial system and the venous compartments of the cavernous sinus (CS) Direct CCFs are when there is a direct fistulous connection between the cavernous sinus and cavernous segment of the internal carotid artery (ICA), it is called direct or type-A CCF and occur secondary to a traumatic tear in the artery from a skull base fracture, from the acceleration-deceleration force of a traumatic injury, or from an iatrogenic injury following an endovascular intervention or a trans-sphenoidal procedure. They can also occur spontaneously following an ICA aneurysm rupture or weakening of the arteries from a genetic condition with subsequent development of chemosis, proptosis, bruit, headache, and/or gradual decrease in vision either unilaterally or bilaterally. High incidence of motor car accidents in Egypt carries a relative high incidence of carotid cavernous fistula. Since direct (type

  1. CCFs are high flow fistulas with acute/ subacute presentation and may cause serious complications, such as permanent vision loss or intracranial hemorrhage, they have to be treated early. CT orbit and MRI often help to confirm the initial diagnosis of CCF demonstrating extraoccularmuscleenlargement,dilatationofoneorbothsuperiorophthalmic veins and enlargement of the affected cavernous sinus.Because of its high spatial and temporal resolution ; the gold standard for evaluation of CCF is digital subtraction angiography; but currently CT angiography is the non invasive modality of choice for its evaluation .Previously surgical intervention included suturing or clipping the fistula, packing the cavernous sinus or ligating the internal carotid artery procedures .Currently endovascular management is the main stay of treatment for patients that fail or not suitable for conservative management and compression therapy. Significant advances in stent and catheter design now make it possible in many instances to deploy covered stents , detachable balloons, detachable coils, both detachable balloons and coils , both detachable and push coils , parent arterial occlusion and using of embolizing materials depending on availability, patient's affordability, type of fistula, and ease of use.Trans femoral catheterization is the main approach. However, trans-radial approach will be considered in patients with advanced iliofemoral diseases
Condition or Disease Intervention/Treatment Phase
  • Procedure: Endovascular management of direct carotid-cavernous fistula

Study Design

Study Type:
Anticipated Enrollment :
1 participants
Intervention Model:
Single Group Assignment
None (Open Label)
Primary Purpose:
Official Title:
Endovascular Management of Direct Carotid-cavernous Fistula
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients with direct carotid cavernous fistula

Endovascular management using coils , detachable balloons or embolizing agents

Procedure: Endovascular management of direct carotid-cavernous fistula
Coiling and embolization of direct carotid-cavernous fistula

Outcome Measures

Primary Outcome Measures

  1. Change in patient proptosis as measured by millimeters after endovascular interventional procedures [6 months]

    Change in patient proptosis measured in millimeters by ruler's test and by plain CT orbit after endovascular management and comparison with the degree of pre-procedural patient proptosis measured in millimeters .

  2. Change in patient visual acuity as assessed by Snellen chart [6 months]

    Change in patient visual acuity assessed by Snellen chart and its comparison with patient pre-procedural vison acuity assessed by Snellen chart.

Secondary Outcome Measures

  1. Assessment of post-procedural change in superior ophthalmic vein caliber measured in millimeters [6 months]

    Change in the caliber of superior ophthalmic vein in millimeters and comparison with the contralateral symptom free side and its comparison with pre-procedural superior ophthalmic vein congestion measured in millimeters .

Eligibility Criteria


Ages Eligible for Study:
10 Years to 75 Years
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Inclusion Criteria:
  • Patients with direct type of carotid cavernous fistula
Exclusion Criteria:
  • End stage renal disease

  • haemodynamically unstable patients.

  • Patients with impaired coagulation profile.

Contacts and Locations


Site City State Country Postal Code
1 Ahmad Tharwat Sohag Egypt 28825

Sponsors and Collaborators

  • Sohag University


None specified.

Study Documents (Full-Text)

None provided.

More Information


None provided.
Responsible Party:
Ahmed Mohamed Tharwat, Resident physician, Sohag University
ClinicalTrials.gov Identifier:
Other Study ID Numbers:
  • Soh-Med-23-9-10MS
First Posted:
Oct 19, 2023
Last Update Posted:
Oct 19, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:
Studies a U.S. FDA-regulated Drug Product:
Studies a U.S. FDA-regulated Device Product:
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2023